The DOI matches its Crossref record; 206 of the 206 references it cites were found in a registry or an index.
Release of mycobacterial antigens
Abstract
Summary: Mycobacterium tuberculosis has evolved from a Mycobacterium canettii‐like progenitor pool into one of the most successful and widespread human pathogens. The pathogenicity of M. tuberculosis is linked to its ability to secrete/export/release selected mycobacterial proteins, and it is also established that active release of mycobacterial antigens is a prerequisite for strong immune recognition. Recent research has enabled mycobacterial secretion systems and vesicle‐based release of mycobacterial antigens to be elucidated, which together with host‐related specificities constitute key variables that determine the outcome of infection. Here, we discuss recently discovered, novel aspects on the nature and the regulation of antigen release of the tuberculosis agent with particular emphasis on the biological characterization of mycobacteria‐specific ESX/type VII secretion systems and their secreted proteins, belonging to the Esx, PE, and PPE categories. The importance of specific mycobacterial antigen release is probably best exemplified by the striking differences observed between the cellular events during infection with the ESX‐1‐deficient, attenuated Mycobacterium bovis BCG compared to the virulent M. tuberculosis, which are clearly important for design of more specific diagnostics and more efficient vaccines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, for ESX-1, ESX-3, and ESX-5, recent research has determined that they all contribute to virulence of M. tuberculosis, although the insights into the exact molecular functions often remain vague; also, because many studies have been undertaken with different mycobacterial species (M.tuberculosis, M. marinum, M. abscessus, and/or Mycobacterium smegmatis), which may show some species-”
From ESX/Type VII Secretion Systems—An Important Way Out for Mycobacterial Proteins (2019) · cites this paper as [26]
Citations
Cites
Items 201–206 of 206
Donà, V., Ventura, M., Sali, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057517 · Cited by 28
Outsmarting the host: bacteria modulating the immune response
Woolard, M. D., & Frelinger, J. A. (2008) · Immunologic Research · doi:10.1007/s12026-008-8021-5 · Cited by 28
Targeting Type VII/ESX Secretion Systems for Development of Novel Antimycobacterial Drugs
Bottai, D., Serafini, A., Cascioferro, A., Brosch, R., & Manganelli, R. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612819666131118170717 · Cited by 21
Self-citationGetting Across the Cell Envelope: Mycobacterial Protein Secretion
van der Woude, A. D., Luirink, J., & Bitter, W. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_298 · Cited by 20
The Complex Relationship between Mycobacteria and Macrophages: It's Not All Bliss
Fortune, S. M., & Rubin, E. J. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.06.008 · Cited by 13
Boritsch, E. C., Supply, P., Honoré, N., et al. (2014) · Molecular Microbiology · doi:10.1111/mmi.12806 · Cited by 3
Flagged first, then by citations
Research works printed but not linked: 3
- 10.1111/j.1365-2958.2004.04261.x · DOI
- Korotkova N, 2014, Structure of the Mycobacterium tuberculosis type VII secretion system chaperone EspG in complex with PE25‐PPE41 dimer, Mol Microbiol, 26, 12770
- Fine PEM, 1999, Issues Relating to the Use of BCG in Immunization Programmes. A Discussion Document
Cited by
Sorted by citations
ESX secretion systems: mycobacterial evolution to counter host immunity
Gröschel, M. I., Sayes, F., Simeone, R., Majlessi, L., & Brosch, R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.131 · Cited by 382
Self-citationSimeone, R., Sayes, F., Song, O., Gröschel, M. I., Brodin, P., Brosch, R., & Majlessi, L. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004650 · Cited by 198
Self-citationGröschel, M. I., Sayes, F., Shin, S. J., Frigui, W., Pawlik, A., Orgeur, M., Canetti, R., Honoré, N., Simeone, R., van der Werf, T. S., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.057 · Cited by 125
Self-citationDumas, E., Christina Boritsch, E., Vandenbogaert, M., Rodríguez de la Vega, R. C., Thiberge, J.-M., Caro, V., Gaillard, J.-L., Heym, B., Girard-Misguich, F., Brosch, R., et al. (2016) · Genome Biology and Evolution · doi:10.1093/gbe/evw001 · Cited by 112
Self-citationESAT-6–dependent cytosolic pattern recognition drives noncognate tuberculosis control in vivo
Kupz, A., Zedler, U., Stäber, M., Perdomo, C., Dorhoi, A., Brosch, R., & Kaufmann, S. H. E. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84978 · Cited by 67
Self-citation
Metadata
- Authors
- Majlessi, L., Prados‐Rosales, R., Casadevall, A., & Brosch, R.
- Affiliations
- Institut Pasteur (FR)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Brosch, Roland
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2015-02-20
- Volume
- 264
- Issue
- 1
- Pages
- 25-45
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2081816898
- Cited by
- 93
- References
- 206
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 7 · 2023: 3 · 2022: 7 · 2021: 8 · 2020: 8 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 17 · 2015: 10
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunological Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Community’s Framework Programme 7 (241745)
- Fondation pour la Recherche Médicale FRM (DEQ20130326471)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- Mycobacterium tuberculosis, antigen secretion, ESX secretion system, type VII secretion system, ESX-1, Mycobacterium bovis BCG, virulence, host-pathogen interaction, tuberculosis vaccine, tuberculosis diagnosis
- MeSH terms
- SEC Translocation Channels, SecA Proteins, Adenosine Triphosphatases, Animals, Antigens, Bacterial, Bacterial Proteins, Biological Transport, Humans, Mycobacterium tuberculosis, Tuberculosis, Secretory Vesicles, Membrane Transport Proteins, Secretory Pathway, Bacterial Secretion Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
